Neuronetics STIM Medical Device — Selling General And Administrative Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neuronetics in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuronetics's medical device — selling general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuronetics's medical device — selling general and administrative expense?
- Neuronetics (STIM) reported medical device — selling general and administrative expense of $7.42M in Q1 2026.
- How has Neuronetics's medical device — selling general and administrative expense changed year-over-year?
- Neuronetics's medical device — selling general and administrative expense decreased by 15.1% year-over-year, from $8.74M to $7.42M.
- What does medical device — selling general and administrative expense mean?
- This metric encompasses the indirect costs associated with operating the medical device segment, including sales force compensation, administrative overhead, and general corporate support. It reflects the level of investment required to maintain and grow the segment's market presence and operational infrastructure.